ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Tenaya Therapeutics Inc

Tenaya Therapeutics Inc (TNYA)

1.985
-0.035
(-1.73%)
終値: 9月28日 5:00AM
1.985
0.003
( 0.15% )
取引時間後: 5:44AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
1.985
買値
1.94
売値
2.17
出来高
369,038
1.97 日の範囲 2.10
1.66 52 週間の範囲 7.01
時価総額
前日終値
2.02
始値
2.04
最終取引時間
06:57:52
財務取引量
US$ 754,899
VWAP
2.0456
平均取引量 (3 か月)
357,668
発行済株式数
78,889,107
配当利回り
-
PER
-1.26
1 株当たり利益 (EPS)
-1.57
歳入
-
純利益
-124.08M

Tenaya Therapeutics Inc について

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and p... Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine. 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Tenaya Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker TNYA. The last closing price for Tenaya Therapeutics was US$2.02. Over the last year, Tenaya Therapeutics shares have traded in a share price range of US$ 1.66 to US$ 7.01.

Tenaya Therapeutics currently has 78,889,107 shares in issue. The market capitalisation of Tenaya Therapeutics is US$159.36 million. Tenaya Therapeutics has a price to earnings ratio (PE ratio) of -1.26.

TNYA 最新ニュース

Tenaya Therapeutics to Participate in Upcoming Investment Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...

Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Received Rare Pediatric Disease Designation from U.S. Food and Drug Administration for TN-201 for MYBPC3-associated Hypertrophic Cardiomyopathy Received UK Clearance to Initiate Clinical Testing...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.135-6.36792452832.122.231.93316842.04238541CS
4-0.795-28.59712230222.782.851.884054822.15297675CS
12-0.915-31.55172413792.94.061.883576682.74545188CS
26-2.905-59.40695296524.895.321.883538273.38350944CS
52-0.945-32.2525597272.937.011.664233283.68604304CS
156-16.745-89.402028830818.73321.643245865.06209263CS
260-17.515-89.820512820519.5321.643235575.7998539CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ZCMDZhongchao Inc
US$ 2.18
(62.08%)
4.52M
GSIWGarden Stage Ltd
US$ 1.53
(26.45%)
5.49M
CMTLComtech Telecommunications Corporation
US$ 5.02
(19.52%)
1.4M
GIGMGigaMedia Ltd
US$ 1.69
(16.55%)
588
CERTCertara Inc
US$ 13.20
(12.34%)
8.75k
ENSCEnsysce Biosciences Inc
US$ 0.218
(-24.31%)
212.27k
HSCSHeart Test Laboratories Inc
US$ 4.50
(-13.29%)
25.24k
SLSSELLAS Life Sciences Group Inc
US$ 1.10
(-12.70%)
39.24k
TBIOTelesis Bio Inc
US$ 2.85
(-11.76%)
86.78k
JFU9F Inc
US$ 2.05
(-10.87%)
190.03k
XPONExpion360 Inc
US$ 0.066
(-8.59%)
9.72M
INTCIntel Corporation
US$ 23.87
(-0.17%)
6.39M
GSIWGarden Stage Ltd
US$ 1.53
(26.45%)
5.49M
ZCMDZhongchao Inc
US$ 2.18
(62.08%)
4.52M
NVDANVIDIA Corporation
US$ 120.82
(-0.48%)
4.49M

TNYA Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock